Additionally, high AKT2 kinase activity is displayed in 40% of breast cancer probes and is associated with late stage tumors, confirming a crucial role of AKT2 in tumor progression rather than in tumor initiation [179]. This evidence concerns the gene AKT2 and neoplasm.